NRXPW vs TROW · rev $242.0K vs P/E 12, rev $3.76B
NRx Pharmaceuticals Inc (NRXPW) versus T. Rowe Price Group Inc (TROW) — a side-by-side from cached financials, not a winner call.
NRx Pharmaceuticals Inc (NRXPW) common stock listed on NASDAQ.
T. Rowe Price Group Inc (TROW) is a asset management company listed on NASDAQ.
Latest reported NRXPW revenue for 2025-09-30 was $242.0K. Net income was -$5.9M. NRXPW currently screens at market cap $714.6M.
Latest reported TROW revenue for 2026-06-30 was $3.76B. Net income was $1.13B. TROW currently screens at market cap $23.17B and trailing P/E 11.6.
NRXPW currently screens at market cap $714.6M. TROW currently screens at market cap $23.17B and trailing P/E 11.6.
Not investment advice. Open the NRXPW and TROW stock pages for the full models.
Not investment advice.